Chi‐Feng Hung

671 citations
25 papers · 476 indexed · h-index 12
Topics
Prostate Cancer Diagnosis and Treatment (3 papers)Prostate Cancer Treatment and Research (3 papers)Cancer, Lipids, and Metabolism (2 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Chi‐Feng Hung

24 papers receiving 467 citations

Peers

Chi‐Feng Hung
Comparison fields: 5 of 97
  • Molecular Biology 145
  • Pulmonary and Respiratory Medicine 101
  • Surgery 99
  • Obstetrics and Gynecology 65
  • Physiology 44
Replace Ebru Kale with:
Ebru Kale Türkiye
Mustafa Çekmen Türkiye
Hong‐I Chen Taiwan
Leonid Bartik United States
Tomasz Pertyński Poland
Serap Çilaker Mıçılı Türkiye
Yun‐Ching Huang Taiwan
Hakan Türkön Türkiye
Buket Demirci Türkiye
Mukaddes Canbaz Türkiye
Chi‐Feng Hung relative to Ebru Kale Türkiye Ebru Kale's profile →
Citations per field
00.5×3.2×
Ebru Kale · 1×
Citations per year

Countries citing papers authored by Chi‐Feng Hung

Since Specialization
Citations

This map shows the geographic impact of Chi‐Feng Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Feng Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Feng Hung more than expected).

Fields of papers citing papers by Chi‐Feng Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Feng Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Feng Hung. The network helps show where Chi‐Feng Hung may publish in the future.

Co-authorship network of co-authors of Chi‐Feng Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Feng Hung. A scholar is included among the top collaborators of Chi‐Feng Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Feng Hung. Chi‐Feng Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 2
5 2
6 2
7 22
8 6
9 7
10 28
11 35
12 20
13 6
14 5
15 47
16 20
17 30
18 5
19 6
20 62

About Chi‐Feng Hung

Chi‐Feng Hung is a scholar working on Transplantation, Urology and Toxicology, having authored 25 papers that have together received 476 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Obstetrics and Gynecology (65 citations), Urology (32 citations) and Biochemistry (21 citations). Chi‐Feng Hung has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Yen‐Chuan Ou, Cheng‐Kuang Yang, Bai‐Luh Wei, Chun‐Nan Lin, Jih-Pyang Wang, Jing‐Ru Weng, Yu‐Ching Chou, Tran‐Der Tan, Chien‐An Sun and Skye Hongiun Cheng. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Clinica Chimica Acta and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026